Introduction
============

*Walk, learn, be active, do!* A large number of messages about healthy behaviors to reduce age-related functional decline has flooded into our daily lives. Aging is related to major risk of cardiovascular diseases, metabolic syndrome, mitochondrial dysfunction, obesity, sarcopenia, and consequent higher inflammation, oxidative stress, and brain and cognitive impairment ([@B84]). Healthy aging has become a matter of interest for the scientific community and for most people and governments that stand for social health policies. Since the aged population is expected to triple by 2100 and will represent 29% of people in the world ([@B106]), we need policies and strategies that enhance independence and quality of life while considering economic, social, environmental, and personal determinants as well as health and social services ([@B114], [@B115]). Cognitive training and aerobic exercise are two lifestyle interventions that have proved to produce positive effects on health ([@B18]; [@B84]), reduce cognitive impairment ([@B42]), and delay the onset of dementia ([@B41]). However, questions about which, when and why remain unclear.

[@B35] define cognitive training as an intervention consisting of repeated practice of standardized exercises targeting a specific cognitive domain or domains. Computerized cognitive training (CCT) has emerged as a new tool to systematically apply these exercises. CCT facilitates the administration by allowing investigators to adapt the content and challenge of the task to individual performance and including visual engaging interfaces ([@B53]; [@B90]). There is evidence that CCT may maintain or improve global cognitive function and specific trained functions such as verbal memory ([@B90]; [@B6]; [@B3]), processing speed ([@B52]; [@B53]; [@B90]), and executive function ([@B52]; [@B6]). Brain related benefits such as increases in gray matter volume of default-mode network (DMN) areas ([@B22]), functional activity of frontal-parietal networks ([@B50]; [@B44]; [@B48]) and connectivity of the hippocampus ([@B61]) and posterior DMN ([@B22]) have also been described. These structural and functional changes appear to be directly related to the types of trained tasks ([@B101]). Despite this, the biological pathways by which CCT produces these effects remain poorly understood in humans. [@B90] hypothesized that these mechanisms might be related to brain neuroplasticity. According to [@B43], a group of neurons that are repeatedly and simultaneously activated will tend to form stronger associations. This framework suggests that CCT may influence cognition by promoting the strength of synaptic connections ([@B72]; [@B101]). Based on animal models, [@B108] suggested that brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) might be the molecules promoting cell survival and proliferation after cognitive stimulation in humans.

Physical activity (PA), defined as any body movement produced by skeletal muscles that results in energy expenditure ([@B15]), promotes health, cognitive and psychological benefits ([@B23]; [@B74]). Exercise, which is considered a planned, structured and repetitive subtype of PA that aims to improve physical fitness ([@B15]), produces an acute body reaction that includes increased energy expenditure, repetitive muscle contractions and an inflammatory and oxidative response ([@B109]; [@B84]). Different types of exercise, applied in a regular manner, may produce different physiological, brain and cognitive benefits ([@B8]; [@B13]). Several systematic reviews conclude that aerobic exercise (AE), the type of exercise that involves oxygen consumption and movement of large groups of skeletal muscles during a sustained period of time ([@B16]; [@B103]), may improve executive function, processing speed, attention and memory in healthy older adults ([@B31]; [@B17]; [@B71]; [@B93]; [@B40]; [@B45]; [@B85]; [@B62]; [@B8]; [@B68]). However, other reviews reported that the evidence was too limited to draw firm conclusions ([@B94]; [@B19]; [@B12]; [@B83]) or reported no significant effects of exercise on cognition ([@B2]; [@B47]; [@B117]). Regular AE has direct effects on our body: higher oxygen and glucose consumption related to increased energy expenditure, and reduction of body fat and increased muscle strength, which have been hypothesized as specific pathways for the physiological relationship between exercise and cognitive function ([@B18]; [@B109]; [@B84]; [@B98]). The increase of energy expenditure reduces visceral fat that may lead to less production of interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-alpha) and an increase of M2:M1 macrophage ratio and the release of adiponectin. Energy expenditure is also related to higher glucose consumption which may be related to better energy metabolism and insulin sensitivity and reducing resistance to leptin and insulin ([@B109]). The activity in the muscles induces IL-ra, IL-10, and heat shock proteins (HSP), reducing the inflammatory environment while suppressing IL-1 and TNF-alpha and upregulating IL-15 and promoting the reparation of the vessels to facilitate blood flow and, as a consequence, oxygen and nutrient circulation ([@B84]). Skeletal muscles may also improve the use of lipids instead of glycogen in energy expenditure processes. Exercise increases circulating HDL and reverses cholesterol transport, reducing cholesterol levels in blood ([@B64]). The activity in the cardiovascular system produces laminar shear stress on vascular endothelial cells which may be related to the downregulation of oxidative processes, and activates the hypothalamic-pituitary-adrenal axis which triggers the release of glucocorticoids that may help to inhibit the inflammatory system. The anti-oxidative response is mediated by redox-sensitive transcription factors: NF-KB and AP-1, which reduce RONS, and PGC-1, which promotes mitochondrial biogenesis ([@B84]). Laminar shear stress is also related to greater release of insulin growth factor (IGF) and vascular endothelial factor (VEGF) which benefits the cardiovascular system, helping to repair the body vasculature and promoting greater blood flow, brain angiogenesis and neurogenesis ([@B18]; [@B84]; [@B98]; [@B13]). IGF promotes the release of BDNF in the brain, which has been identified as one of the principal factors mediating the effect of exercise on cognition. BDNF may support newborn cells, regulate synaptic changes and facilitate long-term potentiation which may be related to the identified brain changes and cognitive benefits ([@B98]; [@B13]). Cardiorespiratory fitness (CRF), the health-related component of physical fitness reflecting these parameters, has shown to be related to better cognitive function in healthy adults ([@B17]). However, [@B30] and [@B117] could not find the relationship between changes in CRF and changes in cognition in their systematic reviews. [@B27] found a positive relationship between PA or CRF and gray matter volume in older adults in prefrontal, temporal and parietal areas ([@B26]; [@B39]; [@B112]). Higher levels of CRF have been also related to greater hippocampus volume and memory performance ([@B28]; [@B100]) and bigger caudate nucleus and nucleus accumbens ([@B110]). However, [@B81] and [@B92] did not find a significant association between PA and gray matter volume. [@B88] systematically reviewed the effects of exercise on white matter volume -- global, local, lesions, and microstructure -- and found cautious support for this association given the fact that evidence was inconsistent. Recent research aims to identify the effect of exercise on functional connectivity. CRF has been associated with higher general efficiency and lower local efficiency and executive function performance ([@B46]). Brain network modularity at baseline may predict the effects of exercise intervention ([@B5]). Other variables have been identified as potential modifiers of the association between exercise and cognition. Groups with a higher percentage of women ([@B9]) or APOE E4 genotype carriers ([@B29]) may benefit more from exercise.

The combination (COMB) of PA and cognitive stimulation may induce greater cognitive benefits compared to each intervention separately ([@B51]; [@B20]; [@B34]; [@B4]; [@B55]; [@B54]). However, [@B91] found improvements only on those participants engaged in cognitive training, single or combined. [@B118] replicated these results in a systematic review of twenty studies, concluding that COMB may have a small positive effect only when compared to a control and physical activity group but not to a cognitive intervention. To our knowledge, the specific cognitive benefits of COMB, in sequence or dual task, remain unknown; undefined "greater effects" or "more enduring" are usually hypothesized. General cognitive function ([@B70]; [@B91]), executive function ([@B1]; [@B102]; [@B7]; [@B24]), processing speed ([@B57]), memory ([@B33]) and vocabulary ([@B87]) performance may tend to benefit more from a COMB. However, evidence is not consistent across trials and negative results have also been found in these same domains ([@B33]; [@B70]; [@B56]; [@B1]; [@B60]; [@B77]). [@B59] and [@B76] reported that a multimodal intervention produced a reorganization of functional connectivity between the DMN areas. [@B89] identified higher verbal memory related to increased glucose metabolism in the brain in the COMB group only. In order to explain these potential greater benefits, [@B69] and [@B32], based on animal models, hypothesized that neuroplasticity may be facilitated by exercise and guided by cognitive training. The anti-inflammatory, anti-oxidative stress and cardiovascular and neural repairing responses related to regular PA may enhance cell proliferation through BDNF. Cognitive stimulation may promote the survival of newborn cells and regulate synaptic changes ([@B43]).

Systematic reviews and papers cited before, independently of the intervention, reported inconsistencies across results which likely relate to genetic and environmental variables of participants; type, duration and schedule of assessments; type, duration, frequency, intensity and adherence of interventions; as well as methodological issues of the design, such as type of control group and statistical approaches ([@B51]; [@B117]; [@B36]). These discrepancies challenge a clear theoretical model and lead to different conclusions and the identification of potential moderators even at the systematic and meta-analytic analysis level. These issues highlight the need to better identify not only the cognitive effects of these interventions but also the individual variables that may predict them and the brain changes and physiological molecular correlates that may be mediating any benefits.

Projecte Moviment is a multi-domain randomized trial that addresses the effect of CCT, AE, and COMB on cognition and psychological status in healthy physically inactive older adults compared to a passive control group. We also aim to identify variables that may predict the effects of the intervention and the underlying brain changes and physiological molecular correlates that may mediate the effects. The purpose of this paper is to describe the protocol in accordance with SPIRIT Guidelines.

Aims of the Study
=================

The primary objective of Projecte Moviment is to examine the effect of CCT, AE, or COMB on cognitive outcomes in healthy physically inactive older adults. The primary hypotheses sustaining this goal are:

1.  Computerized cognitive training -- 5 times per week for 3 months -- will improve general cognitive function as well as trained cognitive functions (executive function, processing speed and memory) measured by composite scores using a battery of validated neuropsychological tests at 3 months compared to a control group.

2.  Aerobic exercise -- 5 times per week for 3 months -- will improve executive function, attention-processing speed and memory measured by composite scores using a battery of validated neuropsychological tests at 3 months compared to a control group.

3.  Combined training -- 5 times per week for 3 months -- will show greater improvements in general cognitive function, executive function, attention-processing speed and memory measured by composite scores using a battery of validated neuropsychological tests at 3 months compared to a control group.

The secondary objectives of Projecte Moviment are: (a) to determine the effects of these interventions on psychological status and subjective performance on daily activities, CRF, brain structure and function and physiological molecular correlates; (b) to identify genetic, demographic, physiological and brain variables that might predict the effect of the intervention; (c) to identify the association between cognitive effects and other psychological, physiological correlates. Specific hypotheses for each objective will be specified in each article when reporting results. General secondary hypotheses include:

1.  All intervention conditions will positively impact psychological and subjective daily functional performance assessed by questionnaires compared to controls.

2.  Aerobic exercise and COMB will similarly increase CRF and energy expenditure in daily activity compared to cognitive and control conditions.

3.  All intervention conditions will positively impact the structure and function of the brain assessed by whole brain analyses, structures of interest and white matter lesions volume and microstructure, cortical thickness and functional connectivity compared to a control group.

4.  Aerobic exercise and COMB will improve immunity, reduce inflammation and improve vascular risk factors compared to cognitive and control conditions.

5.  Individual variables (i.e., sex, age, cognitive baseline, CRF baseline) will predict the effect of the interventions on cognition.

6.  Changes in cognition will be related to specific changes in secondary outcomes depending on the intervention.

Methods
=======

Study Oversight and Schedule
----------------------------

Projecte Moviment is a multi-center, single-blind randomized controlled trial that started November 2015 with the aim of recruiting 140 participants distributed in four parallel groups (one control group, *n* = 20; three intervention groups, *n* = 40 each). All participants give their written informed consent and are assessed at baseline and 3 months later, immediately after the intervention ([Figure 1](#F1){ref-type="fig"}). This study is led by the Faculty of Psychology of the University of Barcelona in collaboration with Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Hospital Germans Trias i Pujol and Institute Guttmann; it was approved by the responsible ethics committees following the Declaration of Helsinki.

![Projecte Moviment study design. CCT, computer-based cognitive training; AE, aerobic exercise; COMB, combined training.](fnagi-11-00216-g001){#F1}

Participants
------------

Participants are 140 community dwelling physically inactive healthy adults aged 50--70 years from Barcelona. Inclusion and exclusion criteria are detailed in [Table 1](#T1){ref-type="table"}. Multiple strategies are applied to recruit participants: distribution of posters and flyers, publication of press releases in local media (newspapers, radio, and TV), presentations in local community organizations, list of patients of general physicians and volunteers from previous studies. Participants are enrolled in primary care centers and can voluntarily withdraw from the project at any time.

###### 

Inclusion and exclusion criteria for Projecte Moviment.

  **Inclusion criteria**                                                           **Exclusion criteria**
  -------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------
  Aged 50--70 years                                                                Current participation in any cognitive training activity or during last 6 months \> 2 h/week
  ≤120 min/week of physical activity during last 6 months                          Diagnostic of dementia or mild cognitive impairment
  Mini-Mental State Examination (MMSE) ≥ 24                                        Diagnostic of neurological disorder: stroke, epilepsy, multiple sclerosis, traumatic brain injury, brain tumor
  Montreal Cognitive Assessment 5-min (MoCA 5-min) ≥ 6                             Diagnostic of psychiatric illness current or during last 5 years
  Competency in Catalan or Spanish                                                 Geriatric Depression Scale (GDS-15) \> 9
  Adequate visual, auditory, and fine motor skills                                 Consumption of psychopharmacological drugs current or during last 5 years; or more than 5 years throughout life
  Acceptance of participation in the study and signature of the informed consent   History of drug abuse or alcoholism current or during last 5 years; or more than 5 years throughout life; \>28 men and \>18 woman unit of alcohol/week
                                                                                   History of chemotherapy
                                                                                   Contraindication to magnetic resonance imaging

MMSE (

Blesa et al., 2001

); MoCA 5-min (

Wong et al., 2015

); GDS-15 (

Martínez et al., 2002

).

Assessments
-----------

Potential participants are screened by phone and an on-site personal interview; if eligible, informed written consent is obtained. Assessments are conducted in a clinical environment and organized into three appointments that take place at baseline -- within 2 weeks prior to the start of the intervention, and again at 3 months within 2 weeks after the completion of the intervention ([Table 2](#T2){ref-type="table"}). (1) Medical assessment (30 min): review of medical history and current health status including cardiovascular risk factors and blood extraction between 8 and 9:30 AM following an overnight fast. (2) Cognitive assessment and physical status (2.5 h): administration of a battery of neuropsychological tests, psychological health, subjective performance, daily activities and PA questionnaires and a treadmill fitness test. In order to control the effects of acute exercise, participants are advised not to exercise prior to all appointments and cognitive tests are conducted before the CRF test. (3) Magnetic Resonance Imaging (MRI) scans (45 min): administration of a neuroimaging protocol to acquire structural and functional data of the brain. All assessments are carried out in two primary care centers except MRI scans that are performed in the Hospital Germans Trias i Pujol. All subjects receive an actimeter the first and last week of intervention to track their daily activity and determine if participants meet the intervention protocol. The same team of psychologists, which administers cognitive tests, and nurses, who collect general health data, follow the protocol in all the centers.

###### 

Assessments.

                                                          **Enrollment and screening**   **Baseline assessments** **(within 2 weeks prior to the start of the intervention)**   **Intervention**   **Post-intervention assessments** **(within 2 weeks after the completion of the intervention)**                              
  ------------------------------------------------------- ------------------------------ -------------------------------------------------------------------------------------- ------------------ ------------------------------------------------------------------------------------------------- --- --- --- --- --- ------ ---
  First review of criteria                                X                                                                                                                                                                                                                                                                     
  Montreal Cognitive Assessment 5-min (MoCA 5-min)        X                                                                                                                                                                                                                                                                     
  Information of study                                    X                              X                                                                                                                                                                                                                                      
  Exhaustive review of criteria                                                          X                                                                                                                                                                                                                                      
  Informed consent form                                                                  X                                                                                                                                                                                                                                      
  Mini-Mental State Examination (MMSE)                                                   X                                                                                                                                                                                                                               X      
  Geriatric Depression Scale (GDS-15)                                                    X                                                                                                                                                                                                                               X      
  Medical history                                                                                                                                                               X                                                                                                                                               
  General health status                                                                                                                                                         X                                                                                                                                    X          
  Blood extraction                                                                                                                                                              X                                                                                                                                    X          
  Battery of neuropsychological tests                                                                                                                                                              X                                                                                                                     X^1^   
  Psychological health and daily activities scales                                                                                                                                                 X                                                                                                                     X      
  Physical activity questionnaire (VREM)                                                                                                                                                           X                                                                                                                     X      
  Cardiorespiratory fitness (Rockport 1-mile walk test)                                                                                                                                            X                                                                                                                     X      
  Magnetic resonance imaging                                                                                                                                                                                                                                                                         X                          X
  Information about intervention                                                                                                                                                                                                                                                                         X                      
  Follow-up adherence questions^2^                                                                                                                                                                                                                                                                           X   X              
  Actimeter^3^ (Polar Loop^®^)                                                                                                                                                                                                                                                                           X       X              
  Intervention follow-up diary^4^                                                                                                                                                                                                                                                                        X   X   X              

1

All of tests except vocabulary subtest;

2

This information is also collected in phone calls every 2 weeks between visits;

3

Participants carry the actimeter the first and last week of training;

4

Participants record the diary every day during the intervention; MoCA 5-min (

Wong et al., 2015

); MMSE (

Blesa et al., 2001

); GDS-15 (

Martínez et al., 2002

); VREM -- Reduced Minnesota leisure time physical activity questionnaire (

Ruiz et al., 2012

); Rockport 1-mile walk test (

Kline et al., 1987

).

Randomization
-------------

Participants are randomly assigned to the groups stratified by sex, age, and education. The allocation sequence consists of a random list of these variables all combined and was generated by a statistician. The intervention staff is responsible for the allocation and informs participants at the first intervention visit. Assessors are blinded to the sequence and the group assignment of the participants. Blinding will only be broken for medical reasons.

Intervention
------------

The intervention consists of a 3 months program, 5 days per week in sessions of 45 min. At baseline all participants receive oral and written information about their specific intervention, an actimeter with brief instructions, and a follow-up diary to monitor the intervention. They are also asked to register hours of sleep during the first and last week of the intervention. AE and COMB groups are also trained to monitor the intensity of their activity using the Borg Rating of Perceived Exertion Scale (BRPES) ([@B11]) while CCT and COMB conditions are informed about the computer program. A follow-up calendar is also created to determine adherence and any interfering events. All participants receive phone calls every 2 weeks, a mid-point intervention visit after 6 weeks and a final visit ([Table 2](#T2){ref-type="table"}).

### Computerized Cognitive Intervention (CCT)

The intervention program consists of a set of multi-domain cognitive tasks targeting executive function, visual and verbal memory and sustained, divided and selective attention using a computerized telerehabilitation platform called Guttmann NeuroPersonal Trainer^®^ (GNPT^®^, Spain; [@B95]; [@B96]). The cognitive functions trained are assessed with the battery of neuropsychological tests. However, the specific training tasks differ from the task performed in the assessment. GNPT includes a variety of exercises designed by neuropsychologist based on cognitive paradigms. The GNPT^®^ platform calculates an individual profile based on age, educational level and the results of the neuropsychological assessment. The demand of the tasks is adjusted according to the performance of previous activities, which allows the software to design a new activity plan adapted to the participant level in each cognitive domain. Training is done individually at home for 45 min per session. Participants without access to a personal computer or Internet can perform the intervention in the health care center. The software records the numbers of sessions and performance in activities automatically.

### Aerobic Exercise (AE)

The training program is based on international guidelines of physical exercise ([@B116]). Participants are instructed to walk briskly in one continuous bout (45 min for 5 days, 225 min per week); intensity and duration are initiated in a stepwise manner in order to reduce the possibility of injury. The first week they must walk 30 min at 9--10 on the BRPES ([@B11]) considered light intensity. Time is increased to 45 min with the same intensity during the second week. During the rest of the program (10 weeks), they maintain the 45 min and increase the intensity of the activity to a moderate-high effort that corresponds with 12--14 in the same scale. Subjects are trained to use the BRPES ([@B11]) and to record this intensity and frequency of activity in a diary.

### Combined Training (COMB)

This group receives both the CCT and the AE intervention. They follow the same previously described instructions for each condition. Participants can organize both tasks at their convenience, always applied in a single continuous bout of 45 min each at any moment of the day. This results in 90 min of daily activity, 5 times per week. We did not set any restriction about the order of the tasks during the day or time-point at which they had to be applied.

### Control Group

Participants in the control group are on the waiting list for 3 months and are asked to keep their normal lifestyle. Once the control condition is finished, they have the option to start one of the interventions (CCT, AE, or COMB). Data of this optional activity will not be included in the trial as they are not considered participants during this period.

Safety Considerations
---------------------

In order to anticipate, prevent and answer medical or personal issues of the participants, several considerations will be taken into account. First, all the assessments are reviewed by the corresponding health professional before randomization to ensure safety during the intervention. Abnormalities identified are reported and these participants are rerouted to the corresponding healthcare service. Participants receive reports of all the assessments. Instructions for each intervention include healthy advice to prevent injuries. Participants can also contact the intervention staff for any problems or pain that they may experience. Adverse events occurring during the intervention are monitored in a diary and sent to a physician in case of medical incident. Participants will be excluded from the trial based on medical recommendation.

Data Management and Results
===========================

Data Quality
------------

A computerized database is used to collect and organize all data. Data is collected without personal identifying information using a code assigned by the assessor and researchers will only have access to this information in case of an incident. Data from all participants will be collected regardless of whether the participant withdraws from the intervention or not. Assessments, individual reports and databases will be double-checked. We will follow Data Quality Assessment Checklist and Recommended Procedures (DQA; [@B107]) that assesses a variety of dimensions as validity, reliability, timeliness, precision and integrity. Regarding interventions parameters, we will assess the coherence between personal diaries, phone-call follow-ups and actimeter. We will analyze if compliance is related to expected physical changes. In addition, if we identify any issues, we will inform and apply any required statistical procedures to control them.

Outcomes
--------

### Primary Outcomes

To address the primary hypothesis, an extensive neuropsychological battery was designed by Projecte Moviment. Each test has been selected for its psychometric qualities and high relevance in the area of study. These tests provide measures of multiple functions: executive functions, visuospatial abilities, memory, language, attention and processing speed. We will calculate z-score composites from normalized raw data for each cognitive domain and a global cognitive function score as a sum of all domains ([Table 3](#T3){ref-type="table"}).

###### 

Primary outcomes: variables and measures.

  **Outcome/Variable**        **Outcome measure**                                     
  --------------------------- --------------------- --------------------------------- -----------
  **Executive function**      Inhibition            Stroop -- Interference            *Z* score
                              Working memory        WAIS III -- Backward span         *Z* score
                                                    TMT -- B                          *Z* score
                              Fluency               Letter fluency                    *Z* score
                                                    Category fluency                  *Z* score
  **Visuospatial function**   Visuospatial          ROCF -- Copy accuracy             *Z* score
  **Memory**                  Verbal memory         RAVLT -- Total learning           *Z* score
                                                    RAVLT -- Recall II                *Z* score
                              Visual memory         ROCF -- Memory accuracy           *Z* score
  **Language**                Language              WAIS III -- Vocabulary            *Z* score
                                                    BNT (15 items)                    *Z* score
  **Attention -- Speed**      Attention             WAIS III -- Forward span          *Z* score
                                                    WAIS III -- Digit symbol coding   *Z* score
                                                    WAIS-III -- Symbol search         *Z* score
                              Speed                 TMT -- A                          *Z* score
                                                    ROCF -- Copy time                 *Z* score

Stroop test (

Golden, 2001

); WAIS-III, Wechsler Adult Intelligence Scale (

Wechsler, 2001

); TMT, Trail Making Test (

Tombaugh, 2004

); Verbal fluency tests (

Peña-Casanova et al., 2009

); ROCF, Rey-Osterrieth Complex Figure (

Rey, 2009

); RAVLT, Rey Auditory Verbal Learning Test (

Schmidt, 1996

;

Marqués et al., 2013

); BNT, Boston Naming Test (

Goodglass et al., 2001

).

### Secondary Outcomes

Several domains are assessed to test secondary hypotheses. Main outcomes and measures are described in [Table 4](#T4){ref-type="table"}.

###### 

Secondary outcomes: variables and measures.

                                            **Variable/Outcome**                                                           **Outcome measure**
  ----------------------------------------- ------------------------------------------------------------------------------ -----------------------------
  **General cognitive function**            Montreal Cognitive Assessment 5-min (MoCA 5-min)                               *Z* score
                                            Mini-mental State Examination (MMSE)                                           *Z* score
  **Psychological health Daily activity**   Geriatric Depression Scales (GDS-15)                                           *Z* score
                                            Modified version of Visual Analog Mood Scale (VAMS)                            *Z* score
                                            Short Informant Questionnaire on Cognitive Decline in the Elderly (S-IQCODE)   *Z* score
                                            Pittsburg Sleep Quality Index (PSQI)                                           *Z* score
                                            Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM)              *Z* score
  **Fitness**                               Cardiorespiratory fitness (Rockport 1-mile walk test)                          VO~2~ max
  **Physical activity**                     Reduced Minnesota leisure time physical activity questionnaire (VREM)          METs
                                            Actimeter activity parameters (Polar Loop^®^)                                  Hours, steps, km, kcal
                                            Actimeter sleeping parameters (Polar Loop^®^)                                  Hours, %
  **Health status**                         Weight, height, and waist diameter                                             Kg, cm
                                            Blood pressure                                                                 mm Hg
                                            Hypertension, diabetes, and dyslipidemia                                       Yes/No
                                            Tobacco and alcohol use                                                        Yes/No, Units
  **Blood sample data**                     Hemogram                                                                       Conventional units
                                            Biochemistry in plasma                                                         Conventional units
                                            Cortisol                                                                       ng/mL
                                            Genetics -- Apolipoprotein E (APOE)                                            E4+/E4-
                                            Genetics -- Brain Derived Neurotrophic Factor (BDNF)                           Met+/Met-
                                            Cytokines                                                                      ng/mL
  **Neuroimaging**                          T1-weighted                                                                    Volume
                                            T2-weighted turbo inversion                                                    Volume
                                            Susceptibility weighted imaging                                                Volume
                                            Resting state                                                                  *Z* score
                                            Diffusion tensor imaging (DTI)                                                 Fractional Anisotropy Index

MoCA 5-min (

Wong et al., 2015

); MMSE (

Blesa et al., 2001

); GDS-15 (

Martínez et al., 2002

); VAMS (

Stern et al., 1997

); S-IQCODE (

Morales et al., 1992

); PSQI (

Rico and Fernández, 1997

); CORE-OM (

Trujillo et al., 2016

); Rockport 1-mile walk test (

Kline et al., 1987

); VREM (

Ruiz et al., 2012

); MET (Metabolic Equivalent of Task).

#### Cognitive decline screening

Montreal Cognitive Assessment 5 min ([@B113]) and Mini-Mental State Examination ([@B10]) assess global cognitive function as relevant markers of cognitive decline.

#### Psychological health and daily activity

Questionnaires ask for depressive symptoms and emotional status, sleep quality and subjective performance in daily activities. These outcomes will test the potential effect of the interventions to enhance perceived psychological status and functionality which may be related to cognitive effects and other secondary outcomes.

#### Aerobic fitness

CRF is assessed by the Rockport 1 mile walk test. Participants are instructed to walk on a treadmill for 1 mile adjusting their speed in order to be as fast as possible without running (Technogym^®^, Italy). Maximal aerobic capacity (VO2 max) will be estimated with the linear regression reported by [@B49]. CRF estimation is a well-known measure of cardiovascular health. We expect to describe the relationship between CRF and the physiological blood measures as well as how change in CRF relate to brain and cognitive outcomes.

#### Physical activity

Information about energy expenditure of PA performed during the last month is obtained by the Reduced Minnesota leisure time PA questionnaire ([@B82]). Polar Loop^®^ actimeter (Polar Electro, NY, United States) registers daily PA (hours, steps, km, kcal) and sleeping (hours, %) parameters. Energy expenditure is the very first consequence of exercising. We aim to identify if baseline energy expenditure is related to baseline CRF and describe how the change in energy expenditure is related to physiological molecular correlates, CRF and to brain and cognitive outcomes.

#### Health status

A nurse registers demographic data, blood pressure, anthropometrics measurements, and cardiovascular risk factors. Demographic data will allow us to control the influence of individual variables. We expect that weight loss could be related to the physiological blood markers and to primary outcomes or other secondary outcomes. The reduction of cardiovascular risk factors is an indirect measure of better cardiovascular health that has been related to exercise.

#### Blood-sample data

Hemogram, biochemical parameters, and lipidic profile will be quantified in a common blood test. Cortisol will be analyzed in plasma and genetic biomarkers in APOE (SNPs rs429358 and rs7412) and BDNF (rs6265) genes will be determined in the buffy coat fraction. Finally, a set of 105 cytokines will be studied semi-quantitatively with The Proteome Profiler Human^TM^ XL Cytokine Array (R&D Systems, MN, United States). Biomarkers with relevant differences within and between groups will be analyzed quantitatively using an ELISA immunoassay method. We have chosen relevant genetic variables and physiological molecular markers that have been related to exercise interventions. We expect to detect changes at 3 months and describe any type of relationship with cognitive outcomes.

#### Neuroimaging

Magnetic Resonance Imaging will be obtained in a Siemens Magnetom Verio Symo MR B17 (Siemens Healthineers, Erlangen, Germany). The protocol includes: (1) T1-weighted multi-planar reformat sequence (voxel: 0.9 × 0.9 × 0.9 mm, TR/TE: 1900/2.73 ms, slices: 192; thickness: 0.9 mm); (2) T2-weighted turbo spin-echo sequence (voxel: 0.7 × 0.5 × 3 mm, TR/TE: 6000/74 ms, slices: 35, thickness: 3 mm); (3) T2-weighted turbo inversion recovery magnitude (voxel: 1 × 0.8 × 3 mm, TR/TE: 9000/99 ms, slices: 44, thickness: 3 mm); (4) Susceptibility-weighted imaging with T2 -- fl3d sequence (TR/TE: 28/20 ms, slices: 88); (5) Resting state imaging with a gradient echo planar imaging sequence (TR/TE: 2000/25 ms, slices: 39, thickness: 3 mm, volumes: 240); (6) Diffusion tensor imaging, echo planar imaging (voxel: 2 × 2 × 2 mm, TR/TE: 10200/89 ms, 64 directions, 1 acquisition). On one side, structural and functional brain outcomes may help identify the molecular changes that are related to changes in brain volume, microstructure and connectivity between groups. On the other, we aim to identify if changes in the MRI outcomes are associated with cognitive changes.

Other parameters from the follow-up such us adherence and type of adverse events will be described.

Analyses
--------

### Power Analysis

The sample size was determined considering previous studies ([@B25]) and the effect size and the standard error of cardiovascular interventions on all cognitive tasks reported in a previous meta-analytic study ([@B17]). We also considered the following assumptions: bilateral contrasts and an effect size of 0.4 using the Tukey--Kramer multiple comparison test at 0.05 significance level with a common standard deviation within a group of 0.3. In order to have at least 80% statistical power to answer the 3 primary aims of the project, we need 18 subjects in the control group and 36 for CCT, AE, and COMB groups, respectively. Assuming 10% of lost to follow up ([@B77]), we need a total sample size of 139 subjects (control group *n* = 19, intervention groups *n* = 40). Sample power has been computed using PASS 14 Power Analysis and Sample Size Software.

### Statistical Analyses

Addressing the primary objective, statistical procedures will be performed with IBM SPSS Statistics 24 and R Environment. The distribution of raw scores will be examined in order to assess data quality (i.e., outliers, skewness) and we will obtain sample *z*-scores for all cognitive tests. Five primary domains will be calculated by adding *z*-scores -- executive function, memory, language, attention-speed, and visuospatial function -- which will be split into nine secondary domains in order to assess specific changes within each domain -- inhibition, fluency, working memory, verbal memory, visual memory, language, attention, speed and visuospatial function (see [Table 3](#T3){ref-type="table"}). Domains will be based on the literature ([@B99]; [@B58]) given the fact that a principle component analysis would not be appropriate for our sample size.

In order to test our primary hypotheses, we will conduct an intention-to-treat (ITT) analysis considering data from all randomized participants, including those that complete and drop-out, in order to prevent attrition bias. An adequate method of imputation will be applied and informed. Parametric or non-parametric tests will be chosen regarding the fitting of data to statistical requirements of the tests and we will follow a coherent pipeline to explore variance: (a) comparison of baseline values between groups to identify potential variables to adjust further analyses; (b) comparison of variables at different time-points for each group to identify the independent effect of each condition; (c) identification of significant cross-time correlations in order to determine whether it is necessary to control for baseline measures; (d) interaction between conditions and time-points to compare interventions. Sex, age, and years of education will be considered covariates beforehand and a two-tailed *p*-value \< 0.05 will be set as the significant threshold and the corresponding correction for multiple comparisons will be applied. In a second phase, we will define a per-protocol (PP) sample including only subjects that finished the intervention with at least 80% adherence and we will reproduce the same pipeline. In case of high disparity between ITT and PP results, we will analyze potential variables related to that discrepancy.

We will analyze our secondary hypotheses following the same pipeline in the per-protocol sample to guarantee that we will be studying the effects of the intervention on the previously described outcomes. We will examine potential mediator effects through relationships between primary and secondary outcomes accounting for the intervention condition using adequate correlational methods and linear mixed models. Structural neuroimaging data will be first processed studying whole brain, hippocampus and frontal lobe volumes and white matter microstructure. In a second phase, connectivity and white matter lesions will be analyzed. Data will be published in several papers where detailed procedures and software packages will be described.

Discussion
==========

Healthy aging is a current social challenge. Lifestyle behaviors such as cognitive training and exercise have a positive impact on health, brain and cognition with the possibility of greater benefits when they are combined. Despite this evidence, there are still many questions remaining unanswered. Questions about the type of activity, length, frequency, duration, and intensity required to observe a cognitive effect, the potential individual predictors of response to the intervention, the relationship between physiological molecular correlates, and structural and functional brain changes and cognitive and psychological benefits remain unclear. Projecte Moviment is a multi-domain intervention trial based on prior evidence that aims to understand the effects of CCT, AE, and COMB on cognitive and psychological outcomes compared to a passive control group and determine related biological correlates as well as significant predictors of their effect. We aim to describe what type of change these specific interventions may produce on biological, cognitive and psychological outcomes at 3 months. These results may support the literature that is currently examining the timeline of the effects of these interventions ([@B98]; [@B13]) on cognition and trying to identify potential related modifiers ([@B8]; [@B68]). We expect to find changes in physiological molecular correlates as well as structural and functional brain outcomes within each intervention group and determine how they differ across groups. Those changes may be related to potential cognitive and psychological improvements depending on adherence, characteristics of the intervention and other individual variables.

Projecte Moviment aims to overcome some of the limitations underlined in relevant reviews ([@B21]; [@B14]). First, we examine several cognitive domains and multiple dimensions of health collecting information at different levels of measure. This fact will allow us to examine the effect on different cognitive domains. We will be able to identify other related variables that may explain the results and differences between groups at a molecular level. To our knowledge, it is one of the first trials to propose a high-frequency program, 5 days per week for 3 months in an ecological environment. We chose a short period of time, used in other trials ([@B75]; [@B78]; [@B63]; [@B13]), but with a higher frequency to examine if we can observe the same or greater biological changes and equivalent or greater related cognitive improvements. A home-based non-reimbursed participation may help us to determine if adherence patterns and effects are like center-based rewarded interventions which might be helpful for clinical guidelines. We will also control the influence of many demographic variables through the eligibility criteria of the sample and age and sex balanced groups.

Nevertheless, we are aware of the limitations of the current study. Highly demanding home-based interventions during a short period of time may result in low adherence and an insufficient amount to test our hypotheses about effects on cognition. Intention to treat and per protocol analyses will help us to describe discrepancies and control attendance. We are also collecting data at a molecular, structural and behavioral level in order to identify the effect of the intervention at multiple biological and behavioral levels. Despite the short duration, [@B98] proposed a timeline of the effects of exercise intervention with changes in the blood and brain parameters within 3 months. In addition, literature suggested that middle-age adults and healthy participants may lead to null results ([@B27]; [@B117]). We believe that replication and deeper examination and understanding of discrepancies is needed. These and future limitations, will be considered when analyzing, interpreting and publishing all results.

Projecte Moviment aims to report results through at least 6 publications in peer-reviewed journals without restrictions to positive or negative results. Conclusions will also be presented in oral communications and posters at national and international conferences. We will inform participants and the general community through educative releases. Projecte Moviment aims to reach health professionals to support the translation of the results of the current study into clinical practice.

Future research will also include a large study of gene expression and metabolites in this sample following big data analytic strategies under the concept of omics to provide a deeper understanding of the biological mechanisms related to these interventions.
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